| Overview |
| bs-15521R-Cy3 |
| IFNA7 Polyclonal Antibody, Cy3 Conjugated |
| WB, IF(IHC-P), IF(IHC-F), IF(ICC) |
| Possible cross-reactivity with IFNA16 |
| Human |
| Specifications |
| Cy3 |
| Rabbit |
| KLH conjugated synthetic peptide derived from human IFNA7 |
| 121-189/189 |
| Polyclonal |
| IgG |
| 1ug/ul |
| Purified by Protein A. |
| Aqueous buffered solution containing 0.01M TBS (pH 7.4) with 1% BSA, 0.03% Proclin300 and 50% Glycerol. |
| Store at -20°C. Aliquot into multiple vials to avoid repeated freeze-thaw cycles. |
| Target |
| 3444 |
| P01567 |
| Secreted |
| IFN alpha 7; IFN alpha J1; IFN alphaJ; IFN-alpha-7; IFN-alpha-J1; IFNA 7; IFNA J; IFNA7; IFNA7_HUMAN; Interferon alpha 7; Interferon alpha family, gene 7; Interferon alpha J; Interferon alpha J1; Interferon alpha-7; Interferon alpha-J; Interferon alpha-J1; LeIF J; OTTHUMP00000021136; OTTMUSP00000012102; RP23-139P14.26. |
| Produced by macrophages, IFN-alpha have antiviral activities. Interferon stimulates the production of two enzymes: a protein kinase and an oligoadenylate synthetase. |
| Application Dilution |
| WB |
1:300-5000 |
| IF(IHC-P) |
1:50-200 |
| IF(IHC-F) |
1:50-200 |
| IF(ICC) |
1:50-200 |
Powered by Bioz